Study of Efficacy and Safety of Secukinumab in Participants With Moderate-severe Rotator Cuff Tendinopathy
Clinical trial NCT05758415 · TERMINATED
Trial details
- NCT number
- NCT05758415
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-02
- Primary completion
- 2024-10-17
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.